For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Mahlow 39110

0 studies enrolling now · 4 studies all time

What they study most

Plaque Psoriasis, Psoriasis

Studies at this site

• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis — Completed